RETRACTED ARTICLE:Regulation of metastasis of bladder cancer cells through the WNT signaling pathway

Tumor Biology

Volumn 36, Issue 11, 2015, Pages 8839-8844

  Du, Yiheng ^a   Wang, Yongchuan ^b   Zhang, Fei ^a   Wu, Wenbo ^a   Wang, Wei ^a   Li, Hao ^a   Xia, Shujie ^a   Liu, Haitao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Weifang Municipal Hospital of Traditional Chinese Medicine   (China)

Author keywords

Bladder cancer (BC); MMP9; WNT signaling; Catenin

Indexed keywords

BETA CATENIN; GELATINASE B; LITHIUM CHLORIDE; MMP9 PROTEIN, HUMAN;

ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER INHIBITION; CELL INVASION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; WNT SIGNALING PATHWAY; BIOSYNTHESIS; BLADDER TUMOR; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LITHIUM CHLORIDE; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTEOLYSIS; URINARY BLADDER NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84949102524     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3563-3     Document Type: TB

References (32)

1. Gray PJ, Shipley WU, Efstathiou JA, Zietman AL. Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancer. Curr Opin Urol. 2013;23:429–34.
2. Kaplan AL, Litwin MS, Chamie K. The future of bladder cancer care in the USA. Nat Rev Urol. 2014;11:59–62.
3. Noon AP, Catto JW. Bladder cancer in 2012: challenging current paradigms. Nat Rev Urol. 2013;10:67–8.
4. Payton S. Bladder cancer: biomarker panel predicts recurrence after radical cystectomy. Nat Rev Urol. 2013;10:309.
5. Tan MY, Mu XY, Liu B, Wang Y, Bao ED, Qiu JX, et al. Sumo-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells. Cell Physiol Biochem. 2013;32:542–8.
6. Kanno T, Gotoh A, Fujita Y, Nakano T, Nishizaki T. A(3) adenosine receptor mediates apoptosis in 5637 human bladder cancer cells by G(q) protein/PKC-dependent AIF upregulation. Cell Physiol Biochem. 2012;30:1159–68.
7. Ao N, Liu Y, Feng H, Bian X, Li Z, Gu B, et al. Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1. Cell Physiol Biochem. 2014;33:1863–75.
8. Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, et al. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cell Physiol Biochem. 2012;30:123–36.
9. Li Q, Li M, Wang YL, Fauzee NJ, Yang Y, Pan J, et al. RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/AKT pathway. Cell Physiol Biochem. 2012;29:361–72.
10. Prins PA, Perati PR, Kon V, Guo Z, Ramesh A, Linton MF, et al. Benzo[a]pyrene potentiates the pathogenesis of abdominal aortic aneurysms in apolipoprotein E knockout mice. Cell Physiol Biochem. 2012;29:121–30.
11. Song H, Pan D, Sun W, Gu C, Zhang Y, Zhao P, et al. SiRNA directed against annexin II receptor inhibits angiogenesis via suppressing MMP2 and MMP9 expression. Cell Physiol Biochem. 2015;35:875–84.
12. Wang R, Ke ZF, Wang F, Zhang WH, Wang YF, Li SH, et al. GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9. Cell Physiol Biochem. 2015;35:969–82.
13. Ahmad R, Shihab PK, Jasem S, Behbehani K. FSL-1 induces MMP-9 production through TLR-2 and NF-kappaB /AP-1 signaling pathways in monocytic THP-1 cells. Cell Physiol Biochem. 2014;34:929–42.
14. Yang CQ, Li W, Li SQ, Li J, Li YW, Kong SX, et al. MCP-1 stimulates MMP-9 expression via ERK 1/2 and p38 MAPK signaling pathways in human aortic smooth muscle cells. Cell Physiol Biochem. 2014;34:266–76.
15. Lee DK, Park EJ, Kim EK, Jin J, Kim JS, Shin IJ, et al. Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB. Cell Physiol Biochem. 2012;30:499–511.
16. Bai Y, Wang L, Li Y, Liu S, Li J, Wang H, et al. High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cell Physiol Biochem. 2006;17:57–68.
17. Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4.
18. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007;17:45–51.
19. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843–50.
20. Barker N, Clevers H. Catenins, Wnt signaling and cancer. Bioessays. 2000;22:961–5.
21. Lin R, Feng J, Dong S, Pan R, Zhuang H, Ding Z. Regulation of autophagy of prostate cancer cells by beta-catenin signaling. Cell Physiol Biochem. 2015;35:926–32.
22. Gu S, Honisch S, Kounenidakis M, Alkahtani S, Alarifi S, Alevizopoulos K, et al. Membrane androgen receptor down-regulates c-src-activity and beta-catenin transcription and triggers GSK-3beta-phosphorylation in colon tumor cells. Cell Physiol Biochem. 2014;34:1402–12.
23. Jiang HL, Xu D, Yu H, Ma X, Lin GF, Ma DY, et al. DAX-1 inhibits hepatocellular carcinoma proliferation by inhibiting beta-catenin transcriptional activity. Cell Physiol Biochem. 2014;34:734–42.
24. Tan M, Gong H, Zeng Y, Tao L, Wang J, Jiang J, et al. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling. J Cell Biochem. 2014;115:1762–7.
25. Varol N, Konac E, Onen IH, Gurocak S, Alp E, Yilmaz A, et al. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24). DNA Cell Biol. 2014;33:408–17.
26. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014;281:1750–8.
27. Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, et al. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 2013;280:4531–8.
28. Wang X, Wang H, Bu R, Fei X, Zhao C, Song Y. Methylation and aberrant expression of the Wnt antagonist secreted frizzled-related protein 1 in bladder cancer. Oncol lett. 2012;4:334–8.
29. Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F, et al. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther. 2009;8:458–68.
30. Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, et al. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res. 2006;12:2109–16.
31. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, et al. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res. 2006;12:383–91.
32. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol. 2003;201:204–12.